Open Access
J Extra Corpor Technol
Volume 50, Number 2, June 2018
Page(s) 120 - 123
Published online 15 June 2018
  1. Stone MJ, Bogen SA Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119:2205–8. [CrossRef] [PubMed] [Google Scholar]
  2. Dimopaulos MA, Panayoitidis P, Moulopoulos LA, et al. Waldenström’s macroglobulinemia: Clinical features, complications, and Management. J Clin Oncol. 2000;18:214–26. [CrossRef] [PubMed] [Google Scholar]
  3. Stone MJ, Bogen SA Role of plasmapheresis in Waldenström’s macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013;13:238–40. [CrossRef] [PubMed] [Google Scholar]
  4. Sweeting CA, Kelleher N, Mahmood N, et al. Waldenström’s disease and cardiopulmonary bypass: A case report. Perfusion. 2004;19:381–3. [CrossRef] [PubMed] [Google Scholar]
  5. Murphy GS, Hessel EA, Groom RC Optimal perfusion during cardiopulmonary bypass: An evidence based approach. Anesth Analg. 2009;108:1394–417. [CrossRef] [PubMed] [Google Scholar]
  6. Jenkins IR, Curtis AP The combination of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass. Perfusion. 1995;10:301–5. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.